Remel Blood Agar Bi-Plate Recall: May Not Grow Patient Isolates
Remel recalls Blood Agar/MacConkey Agar Bi-Plates (Lot 150237) due to potential failure to grow patient isolates or QC organisms. Affected users should contact Remel for details.
Lower-risk recall
The blood agar side of the bi-plate may not grow some patient isolates or QC organisms as intended.
Contact the company
What happened, in plain English
Remel is recalling Blood Agar/MacConkey Agar Bi-Plates that may not grow some patient isolates or quality control organisms as intended. This could affect lab results and patient care. Read more at govinfonow.com/recall/63687-remel-blood-agar-bi-plate-recall-may-not-grow-patient.
Source Summary by GovInfoNow · govinfonow.com/recall/63687-remel-blood-agar-bi-plate-recall-may-not-grow-patient · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0769-2021
Cite this page
“Remel Blood Agar Bi-Plate Recall: May Not Grow Patient Isolates.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63687-remel-blood-agar-bi-plate-recall-may-not-grow-patient. Based on FDA recall #Z-0769-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0769-2021%22&limit=1).
Why it’s dangerous
The blood agar side of the bi-plate may not grow certain patient isolates or quality control organisms properly. This could lead to inaccurate lab results or missed diagnoses.
Who’s affected
Lab technicians and healthcare facilities using Remel Blood Agar/MacConkey Agar Bi-Plates with Lot 150237 are most at risk. The recall affects specific laboratory products.
How to tell if you have this one
Check for the lot number 150237 on the Remel Blood Agar/MacConkey Agar Bi-Plate packaging. The product was sold under the reference number R02049.
- Brand
Remel- Category
Medical device
What to do — step by step
Check Product Lot Number
Look for the lot number 150237 on the Remel Blood Agar/MacConkey Agar Bi-Plate packaging.
Where it went and when
Where it was distributed
Distributed in 8 states.
FDA distribution: “Distribution in United States - AL, FL, GA, LA MS, NC, SC, TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee.
Recall timeline
FDA terminated this recall 2.6 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury from this product?
The recall is for potential inaccurate lab results, not a physical safety hazard.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0769-2021 (December 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0769-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.